SMTL ID : 7oa0.1

Crystal structure of di-phosphorylated human CLK1 in complex with 5-(6,7-dichloro-1H-indol-3-yl)pyrimidin-4-amine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.81 Å

Oligo State

monomer

Ligands

1 x JTQ: 5-[6,7-bis(chloranyl)-1-methyl-indol-3-yl]pyrimidin-4-amine(Non-covalent)

JTQ.1: 13 residues within 4Å: Chain A: L.20, F.25, V.28, A.42, K.44, F.94, E.95, L.97, E.145, N.146, L.148, V.177, D.178 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:V.28, A:F.94, A:V.177 Hydrogen bonds: A:N.146, A:D.178 Water bridges: A:L.20, A:D.178

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Livnah, O. et al., Development of novel CLK1 inhibitors as potential drugs for treatment of Chikungunya virus infections. To Be Published

Release Date

2022-05-04

Peptides

Dual specificity protein kinase CLK1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
AAA

Dual specificity protein kinase CLK1

Related Entries With Identical Sequence